Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1

Interventions

Cyclophosphamide 516 Bevacizumab 487 Carboplatin 424 pembrolizumab 384 Paclitaxel 384 Gemcitabine 372 Cisplatin 366 Docetaxel 323 Rituximab 316 Radiotherapy 295 Nivolumab 247 Doxorubicin 243 Dexamethasone 239 Fluorouracil 225 Capecitabine 214 Oxaliplatin 211 Erlotinib Hydrochloride 206 fludarabine phosphate 200 Etoposide 187 Cetuximab 184 Lenalidomide 176 Pemetrexed 175 Bortezomib 174 Trastuzumab 173 Filgrastim 171 fludarabine 166 Prednisone 166 Leucovorin 166 Cytarabine 165 Irinotecan 161

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Has results × Inhalation × Clear all

NCT04481035 2026-04-21

NF1NAC

Children's Hospital Medical Center, Cincinnati

Phase 2 Completed

5 enrolled 10 charts

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡